SLC13A2-transported citrate is a metabolic signal for PKM2 acetylation and degradation to suppress tumor growth
J. Xiong, H. Hao, M. Qin, L. Shi, H. Chen, C. Liu, Z. Tang, D. An, W. Yu, D. He, C. Shao, S. Yuan, H. Yu
This paper identifies SLC13A2-transported citrate as a metabolic signal that promotes PKM2 acetylation and degradation, thereby suppressing tumor growth in hepatocellular carcinoma.
bioRxiv · May 4, 2024 · PreprintCancer Biology